Matt Miksic

Analyst

Credit Suisse

Equibles does not estimate personal net worth.

About Matt Miksic

Matt Miksic is recorded as Analyst at Credit Suisse. Matt Miksic has spoken on 2 earnings calls across 2 companies, most recently for Zimmer Biomet Holdings, Inc. on February 7, 2022. Those appearances were for Zimmer Biomet Holdings, Inc. (ZBH) and Johnson & Johnson (JNJ). The companies whose calls Matt Miksic spoke on are classified in the Healthcare sector.

Matt Miksic on recent calls

“Just one question if I could on the strength in EMEA knees was one question that I thought would be worth flushing out if you have just a minute, and I'll just leave it at that.”

Analyst — Credit Suisse, Zimmer Biomet Holdings, Inc. Q4 FY2021 Earnings Call · February 7, 2022

“I have one utilization-related question on procedure trends and then a follow-up on digital strategy. Device is up 8.8%, stronger than expected. The mix was a bit stronger on advanced surgery and knees are slower.”

Analyst — Credit Suisse, Johnson & Johnson Q1 FY2021 Earnings Call · April 20, 2021